EMPEROR-Preserved Score Predicts Outcomes and Identifies Greater Absolute Benefit with Finerenone
In the FINEARTS-HF Trial, the EMPEROR-Preserved Trial risk score showed broad applicability across outcomes. While baseline risk did not alter the relative treatment effect of Finerenone, higher-risk patients derived greater…